144 related articles for article (PubMed ID: 19903040)
21. Insulin resistance and hyperandrogenism have no substantive association with birth weight in adolescents with polycystic ovary syndrome.
Fulghesu AM; Manca R; Loi S; Fruzzetti F
Fertil Steril; 2015 Mar; 103(3):808-14. PubMed ID: 25637475
[TBL] [Abstract][Full Text] [Related]
22. Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life.
Pinola P; Puukka K; Piltonen TT; Puurunen J; Vanky E; Sundström-Poromaa I; Stener-Victorin E; Lindén Hirschberg A; Ravn P; Skovsager Andersen M; Glintborg D; Mellembakken JR; Ruokonen A; Tapanainen JS; Morin-Papunen LC
Fertil Steril; 2017 Mar; 107(3):788-795.e2. PubMed ID: 28089571
[TBL] [Abstract][Full Text] [Related]
23. Utility of the Oral Glucose Tolerance Test to Assess Glucose Abnormalities in Adolescents with Polycystic Ovary Syndrome.
Coles N; Bremer K; Kives S; Zhao X; Hamilton J
J Pediatr Adolesc Gynecol; 2016 Feb; 29(1):48-52. PubMed ID: 26358939
[TBL] [Abstract][Full Text] [Related]
24. Extent of metabolic risk in adolescent girls with features of polycystic ovary syndrome.
Hart R; Doherty DA; Mori T; Huang RC; Norman RJ; Franks S; Sloboda D; Beilin L; Hickey M
Fertil Steril; 2011 Jun; 95(7):2347-53, 2353.e1. PubMed ID: 21450287
[TBL] [Abstract][Full Text] [Related]
25. Impact of Autoimmune Thyroiditis on Reproductive and Metabolic Parameters in Patients with Polycystic Ovary Syndrome.
Ulrich J; Goerges J; Keck C; Müller-Wieland D; Diederich S; Janssen OE
Exp Clin Endocrinol Diabetes; 2018 Apr; 126(4):198-204. PubMed ID: 29506313
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of polycystic ovary syndrome under NIH criteria among the tenth-grade Chinese schoolgirls in Guangzhou area: a cross-sectional epidemiological survey.
Hong Y; Zhou ZH; Dong Z; Yang DZ
BMC Womens Health; 2023 Jan; 23(1):31. PubMed ID: 36681820
[TBL] [Abstract][Full Text] [Related]
27. Defining Hyperandrogenism in Women With Polycystic Ovary Syndrome: A Challenging Perspective.
Pasquali R; Zanotti L; Fanelli F; Mezzullo M; Fazzini A; Morselli Labate AM; Repaci A; Ribichini D; Gambineri A
J Clin Endocrinol Metab; 2016 May; 101(5):2013-22. PubMed ID: 26964728
[TBL] [Abstract][Full Text] [Related]
28. Metabolic abnormalities in adolescents with polycystic ovary syndrome in south China.
Huang J; Ni R; Chen X; Huang L; Mo Y; Yang D
Reprod Biol Endocrinol; 2010 Nov; 8():142. PubMed ID: 21083920
[TBL] [Abstract][Full Text] [Related]
29. Metabolic effect of obesity on polycystic ovary syndrome in adolescents: a meta-analysis.
Li L; Feng Q; Ye M; He Y; Yao A; Shi K
J Obstet Gynaecol; 2017 Nov; 37(8):1036-1047. PubMed ID: 28657375
[TBL] [Abstract][Full Text] [Related]
30. ACC/AHA 2017 definition of high blood pressure: implications for women with polycystic ovary syndrome.
Marchesan LB; Spritzer PM
Fertil Steril; 2019 Mar; 111(3):579-587.e1. PubMed ID: 30827526
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.
Feng JG; Guo Y; Ma LA; Xing J; Sun RF; Zhu W
J Cosmet Dermatol; 2018 Jun; 17(3):511-517. PubMed ID: 28940857
[TBL] [Abstract][Full Text] [Related]
32. Androgen Profile Through Life in Women With Polycystic Ovary Syndrome: A Nordic Multicenter Collaboration Study.
Pinola P; Piltonen TT; Puurunen J; Vanky E; Sundström-Poromaa I; Stener-Victorin E; Ruokonen A; Puukka K; Tapanainen JS; Morin-Papunen LC
J Clin Endocrinol Metab; 2015 Sep; 100(9):3400-7. PubMed ID: 26192874
[TBL] [Abstract][Full Text] [Related]
33. [Obesity, hormonal and metabolic abnormalities in adolescent girls with polycystic ovary syndrome].
Ságodi L; Lombay B; Vámosi I; Barkai L
Orv Hetil; 2013 Aug; 154(31):1226-34. PubMed ID: 23895991
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria.
Huang A; Brennan K; Azziz R
Fertil Steril; 2010 Apr; 93(6):1938-41. PubMed ID: 19249030
[TBL] [Abstract][Full Text] [Related]
35. Metabolic inflexibility in women with polycystic ovary syndrome: a systematic review.
Rimmer M; Tan BK; Teede H; Thangaratinam S; H Al Wattar B
Gynecol Endocrinol; 2020 Jun; 36(6):501-507. PubMed ID: 31793357
[TBL] [Abstract][Full Text] [Related]
36. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
[TBL] [Abstract][Full Text] [Related]
37. An inverse association between serum soluble receptor of advanced glycation end products and hyperandrogenism and potential implication in polycystic ovary syndrome patients.
Liao Y; Huang R; Sun Y; Yue J; Zheng J; Wang L; Tao T; Ma J; Li S; Liu W
Reprod Biol Endocrinol; 2017 Jan; 15(1):9. PubMed ID: 28125989
[TBL] [Abstract][Full Text] [Related]
38. Adolescent polycystic ovary syndrome due to functional ovarian hyperandrogenism persists into adulthood.
Rosenfield RL; Ehrmann DA; Littlejohn EE
J Clin Endocrinol Metab; 2015 Apr; 100(4):1537-43. PubMed ID: 25675386
[TBL] [Abstract][Full Text] [Related]
39. Ovarian hyperandrogenism in adolescents and young women with type I diabetes is primarily related to birth weight and body mass index.
Bizzarri C; Benevento D; Ravà L; Patera IP; Schiaffini R; Ciampalini P; Giannone G; Cappa M
Fertil Steril; 2011 Dec; 96(6):1497-1502.e1. PubMed ID: 21982726
[TBL] [Abstract][Full Text] [Related]
40. Polycystic ovarian syndrome: the commonest cause of hyperandrogenemia in women as a risk factor for metabolic syndrome.
Diamanti-Kandarakis E; Christakou C; Kandarakis H
Minerva Endocrinol; 2007 Mar; 32(1):35-47. PubMed ID: 17353865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]